Optimizing clinical trials and research operations with Salesforce

Clinical trials are becoming more operationally demanding, data-intensive, and patient-centric than ever before. Pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and medical device manufacturers are under constant pressure to accelerate drug development timelines while improving patient outcomes and maintaining strict regulatory compliance. At the same time, decentralized clinical trials, AI-enabled analytics, and growing interoperability requirements are fundamentally changing how research organizations manage study execution.

Many life sciences organizations still rely on disconnected systems, siloed data environments, spreadsheets, and manual workflows that limit visibility across clinical operations. These inefficiencies create delays in patient recruitment, increase administrative overhead, complicate compliance efforts, and reduce operational agility. The rapid expansion of decentralized and hybrid clinical trial models has accelerated the need for more digitally connected operational frameworks.

Salesforce is increasingly being adopted as a strategic platform for modernizing clinical trial operations and research management. Through Agentforce and related technologies such as Data 360 and MuleSoft, Salesforce enables organizations to unify clinical, operational, and patient engagement processes into a connected ecosystem designed to improve study efficiency and support more patient-centric research models.

Why clinical trial operations need modernization

Clinical trials have evolved significantly over the past decade. Modern studies often involve geographically distributed participants, hybrid engagement models, wearable technologies, electronic patient-reported outcomes (ePROs), and real-time data streams from multiple systems and devices. While these innovations create opportunities for better patient access and richer datasets, they also introduce substantial operational complexity.

Research teams frequently struggle with fragmented workflows that make it difficult to coordinate communication between sponsors, CROs, investigators, clinical sites, and patients. These operational gaps can delay enrollment timelines, increase study costs, and create compliance risks. Several operational issues continue to impact trial performance across the industry:

Disconnected clinical and operational systems
Limited visibility into site performance and recruitment metrics
Manual patient engagement processes
Delayed data sharing between research stakeholders
Increasing regulatory complexity
Inconsistent participant experiences
Difficulty scaling decentralized trial models

Organizations increasingly recognize that modern research operations require unified digital platforms capable of connecting data, automating workflows, and improving collaboration across the entire clinical trial lifecycle.

How Salesforce supports clinical trial optimization

Salesforce has expanded its healthcare and life sciences capabilities to support clinical operations, patient engagement, and research management. Agentforce Life Sciences combines CRM functionality, AI-driven automation, workflow orchestration, analytics, and interoperability tools to help organizations streamline study execution and improve operational visibility. (salesforce.com)

The platform is designed to support both traditional and decentralized clinical trial models by centralizing patient, investigator, and operational data into a single connected environment. Salesforce also integrates with existing research infrastructure, allowing organizations to modernize operations without completely replacing legacy clinical systems.

Core Salesforce capabilities for research operations include:

Participant recruitment and enrollment management
Investigator and site relationship management
AI-powered workflow automation
Patient engagement and communications
Data interoperability across systems
Compliance and consent management
Real-time operational dashboards
Integration with EHRs, CTMS, and external data sources

By consolidating these functions onto a unified platform, life sciences organizations can reduce operational silos and improve coordination across research stakeholders.

Accelerating patient recruitment and enrollment

Patient recruitment remains one of the largest drivers of clinical trial delays and rising research costs. Traditional recruitment strategies often rely on fragmented outreach efforts, manual screening processes, and limited visibility into participant engagement. These inefficiencies make it difficult to identify eligible candidates quickly and maintain enrollment momentum throughout the study lifecycle.

Salesforce addresses this challenge through participant recruitment and enrollment workflows designed to centralize patient data, automate outreach, and improve engagement tracking. Agentforce enables organizations to leverage AI and unified data to support more personalized participant experiences and streamline onboarding processes. The platform supports recruitment optimization through capabilities such as:

AI-enabled participant matching
Automated communication workflows
Recruitment tracking dashboards
Personalized patient outreach
Enrollment funnel visibility
Participant engagement monitoring

These capabilities become especially important in decentralized and hybrid trials where organizations must coordinate digital interactions across multiple patient touchpoints. Decentralized models can improve accessibility and convenience for participants by reducing the need for frequent in-person visits.

Improved engagement strategies can help organizations reduce dropout rates, increase enrollment velocity, and support broader demographic participation across clinical studies.

Improving site and investigator management

Clinical trial success depends heavily on effective collaboration between sponsors, CROs, investigators, and research sites. However, many organizations continue to manage these relationships using disconnected communication tools and manual reporting processes that limit operational visibility.

Salesforce provides centralized site and investigator management capabilities that allow organizations to monitor study progress, manage communications, and improve collaboration across research networks. By consolidating operational data into a shared platform, teams can identify bottlenecks earlier and respond more quickly to enrollment or performance issues. Key site management capabilities include:

Centralized investigator profiles
Site activation tracking
Automated workflow management
Real-time operational dashboards
Cross-functional collaboration tools
Study milestone monitoring

Salesforce also uses AI-driven recommendations to help organizations identify investigators and facilities that align with specific study requirements. This can improve site selection strategies while reducing administrative overhead associated with trial startup activities.

Better operational coordination enables sponsors and CROs to improve execution consistency across distributed site networks while maintaining stronger oversight throughout the study lifecycle.

Supporting decentralized clinical trials

Decentralized clinical trials (DCTs) have become a major focus area for life sciences organizations seeking to improve patient accessibility and operational flexibility. Hybrid models combine virtual and in-person interactions through telehealth services, wearable devices, remote monitoring technologies, and digital engagement platforms.

The growth of decentralized trials has increased the demand for platforms capable of managing large volumes of real-time patient and operational data. Salesforce supports these models through integrated communication tools, mobile-enabled workflows, and interoperability capabilities that connect research stakeholders across digital environments. Salesforce capabilities supporting decentralized trials include:

Remote patient engagement tools
Digital communication workflows
Mobile-enabled participant interactions
AI-powered next-best-action recommendations
Integrated patient data management
Real-time operational visibility

Research published on decentralized clinical trial methodologies highlights the growing importance of data integrity, endpoint validation, security, and interoperability in remote study environments.

As decentralized trials continue expanding across the industry, organizations require scalable operational frameworks capable of integrating remote technologies while maintaining compliance and data quality standards.

Enhancing patient engagement and retention

Patient engagement has become a critical factor in clinical trial success. Participants increasingly expect personalized, consumer-grade digital experiences similar to those offered in retail banking, e-commerce, and modern healthcare delivery. Poor communication and fragmented engagement processes contribute significantly to participant attrition and incomplete study data.

Salesforce focuses heavily on improving participant experiences through personalized communication and connected engagement workflows. Unified patient profiles enable research teams to deliver more relevant interactions throughout the trial lifecycle while improving visibility into participant needs and behaviors. Patient engagement capabilities include:

Personalized communication workflows
Omnichannel engagement tools
Automated reminders and follow-ups
Digital consent management
Participant support services
Patient-reported outcome collection

These capabilities help organizations improve retention while reducing administrative burdens placed on research coordinators and support teams.

Patient-centric engagement models are becoming increasingly important as healthcare and life sciences organizations prioritize digital transformation initiatives focused on experience optimization and operational efficiency.

Leveraging AI and automation in clinical research

Artificial intelligence is rapidly becoming a strategic priority across the life sciences industry. Organizations are looking for ways to reduce administrative workloads, improve operational forecasting, and accelerate data-driven decision-making across clinical operations.

Salesforce integrates AI capabilities throughout its life sciences platform using Agentforce and Data 360 technologies. These tools help organizations automate repetitive tasks, analyze operational trends, and generate recommendations that improve study execution efficiency. AI-enabled use cases within clinical research operations include:

Predictive enrollment analytics
Intelligent participant matching
Automated workflow orchestration
Site performance forecasting
Risk identification and alerts
Operational reporting automation

AI can also improve visibility into potential recruitment delays, participant retention risks, and site performance issues before they escalate into major operational problems.

As life sciences organizations continue investing in digital transformation, AI-driven operational intelligence is expected to play a larger role in improving clinical trial efficiency and accelerating research timelines.

Strengthening compliance and data governance

Clinical trials operate within highly regulated environments that require strict controls around patient privacy, data integrity, auditability, and consent management. As decentralized trial models increase the number of digital interactions and connected systems involved in study execution, compliance complexity continues to grow.

Salesforce includes compliance-focused capabilities designed to help organizations maintain governance standards while improving operational flexibility. According to Salesforce, the platform supports secure data management frameworks, audit tracking, consent management, and role-based access controls.

Compliance and governance features include:

Digital consent management
Audit trail visibility
Role-based security controls
E-signature support
Secure data sharing frameworks
Regulatory reporting support

Centralized operational environments help organizations reduce the risks associated with fragmented systems and inconsistent data governance practices.

This becomes increasingly important as organizations manage global research programs that must comply with HIPAA, GDPR, FDA requirements, and other evolving regulatory standards.

Integrating research ecosystems with MuleSoft and Data 360

Clinical research organizations rely on extensive technology ecosystems that often include electronic data capture systems, clinical trial management systems, electronic health records, laboratory platforms, wearable devices, and patient engagement applications. Integrating these environments is critical for maintaining operational visibility and data consistency.

Salesforce extends its interoperability capabilities through MuleSoft and Data 360, enabling organizations to connect disparate systems and unify research data into centralized operational profiles. Integration capabilities support:

Real-time data synchronization
Unified patient and operational profiles
Cross-system workflow automation
API-driven interoperability
Connected analytics and reporting
Reduced manual data entry

MuleSoft enables organizations to streamline data exchange across research environments, while Data 360 helps consolidate structured and unstructured data into connected operational insights.

This integrated architecture improves collaboration across research teams while helping organizations scale more advanced analytics and AI initiatives.

The future of clinical trial operations

The future of clinical research will be increasingly driven by AI, interoperability, patient-centric engagement, and decentralized operational models. Life sciences organizations are investing heavily in platforms capable of supporting connected digital ecosystems that improve efficiency while enhancing participant experiences.

Salesforce is positioning Agentforce Life Sciences as a unified platform designed to support this transformation by combining CRM capabilities, workflow automation, analytics, AI, and interoperability into a scalable architecture. Several trends are expected to shape the next generation of clinical operations:

Expansion of decentralized and hybrid trial models
Increased use of AI-driven operational intelligence
Greater integration of real-world evidence
Stronger emphasis on patient-centric engagement
Higher demand for interoperable research ecosystems
Accelerated adoption of automation technologies

Organizations that modernize their research infrastructure now will be better positioned to improve operational agility, accelerate innovation, and support evolving patient and regulatory expectations.

Start your transformation with TELUS Digital

Clinical trials are becoming more complex, distributed, and digitally connected. Legacy operational models built around disconnected systems and manual workflows are increasingly unable to support the speed, scalability, and patient-centricity required in modern research environments.

Salesforce provides life sciences organizations with a connected platform for optimizing clinical trial operations, participant engagement, decentralized research management, and data interoperability. Through AI-enabled automation, integrated workflows, and unified operational visibility, Salesforce helps organizations streamline study execution while improving collaboration across sponsors, CROs, investigators, and patients.

As the life sciences industry continues evolving toward more connected and data-driven research models, organizations that invest in scalable digital platforms will be better equipped to accelerate clinical innovation, improve patient experiences, and drive more efficient trial outcomes.

‍

Blog